1. Home
  2. AMPH vs EVV Comparison

AMPH vs EVV Comparison

Compare AMPH & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • EVV
  • Stock Information
  • Founded
  • AMPH 1996
  • EVV 2003
  • Country
  • AMPH United States
  • EVV United States
  • Employees
  • AMPH N/A
  • EVV N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • EVV Finance/Investors Services
  • Sector
  • AMPH Health Care
  • EVV Finance
  • Exchange
  • AMPH Nasdaq
  • EVV Nasdaq
  • Market Cap
  • AMPH 1.2B
  • EVV 1.2B
  • IPO Year
  • AMPH 2014
  • EVV N/A
  • Fundamental
  • Price
  • AMPH $23.94
  • EVV $9.69
  • Analyst Decision
  • AMPH Hold
  • EVV
  • Analyst Count
  • AMPH 3
  • EVV 0
  • Target Price
  • AMPH $43.50
  • EVV N/A
  • AVG Volume (30 Days)
  • AMPH 670.7K
  • EVV 323.7K
  • Earning Date
  • AMPH 05-07-2025
  • EVV 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • EVV 9.66%
  • EPS Growth
  • AMPH 17.69
  • EVV N/A
  • EPS
  • AMPH 3.06
  • EVV N/A
  • Revenue
  • AMPH $731,967,000.00
  • EVV N/A
  • Revenue This Year
  • AMPH $2.15
  • EVV N/A
  • Revenue Next Year
  • AMPH $6.64
  • EVV N/A
  • P/E Ratio
  • AMPH $7.68
  • EVV N/A
  • Revenue Growth
  • AMPH 13.59
  • EVV N/A
  • 52 Week Low
  • AMPH $22.64
  • EVV $8.52
  • 52 Week High
  • AMPH $53.96
  • EVV $10.07
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 36.03
  • EVV 49.83
  • Support Level
  • AMPH $22.84
  • EVV $9.44
  • Resistance Level
  • AMPH $24.69
  • EVV $9.65
  • Average True Range (ATR)
  • AMPH 1.17
  • EVV 0.23
  • MACD
  • AMPH 0.02
  • EVV 0.03
  • Stochastic Oscillator
  • AMPH 22.26
  • EVV 86.11

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.

Share on Social Networks: